Literature DB >> 27193635

Label-free analysis of mRNA capping efficiency using RNase H probes and LC-MS.

Michael Beverly1, Amy Dell2, Parul Parmar2, Leslie Houghton2.   

Abstract

A label-free method for determining the 5'-end cap identity and orientation of a messenger RNA (mRNA) is described. Biotin-tagged probes that were complementary to the 5' end of target mRNA were used with RNase H to cleave the 5' end of the mRNA. The cleaved end sequence was isolated using streptavidin-coated magnetic beads and then analyzed by LC-MS. Quantitative and qualitative information on the 5' cap was determined from the unique mass of the isolated cleaved sequence. This approach, combined with the use of 5' RNA pyrophosphohydrolase, was also used to ascertain the orientation of the 5' cap. The assay showed low-picomole sensitivity for detecting capping reaction impurities. Uncapped triphosphate mRNA, spiked into 100 pmol of capped mRNA, could be detected over the tested range of 0.5 to 25 % with a linear response. The capping efficiency of several vaccinia-capped mRNA preparations was determined to be between 88 and 98 % depending on the modification type and length of the mRNA. mRNA of 2.2K and 9K nucleotides in length and containing the modified nucleotides pseudouridine and 5-methylcytidine were all successfully analyzed, demonstrating the utility of the technique to study mRNA capping. Graphical abstract mRNA 5' end analysis with RNAse H cleavage and capture probe.

Entities:  

Keywords:  5′ cap; LC-MS; N7-Methylguanosine; RNA; RNase H; mRNA

Mesh:

Substances:

Year:  2016        PMID: 27193635     DOI: 10.1007/s00216-016-9605-x

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  14 in total

Review 1.  mRNA-based therapeutics: powerful and versatile tools to combat diseases.

Authors:  Shugang Qin; Xiaoshan Tang; Yuting Chen; Kepan Chen; Na Fan; Wen Xiao; Qian Zheng; Guohong Li; Yuqing Teng; Min Wu; Xiangrong Song
Journal:  Signal Transduct Target Ther       Date:  2022-05-21

2.  RNase H-based analysis of synthetic mRNA 5' cap incorporation.

Authors:  S Hong Chan; Joseph M Whipple; Nan Dai; Theresa M Kelley; Kathryn Withers; George Tzertzinis; Ivan R Corrêa; G Brett Robb
Journal:  RNA       Date:  2022-06-09       Impact factor: 5.636

3.  CAP-MAP: cap analysis protocol with minimal analyte processing, a rapid and sensitive approach to analysing mRNA cap structures.

Authors:  Alison Galloway; Abdelmadjid Atrih; Renata Grzela; Edward Darzynkiewicz; Michael A J Ferguson; Victoria H Cowling
Journal:  Open Biol       Date:  2020-02-26       Impact factor: 6.411

4.  Label-free, direct localization and relative quantitation of the RNA nucleobase methylations m6A, m5C, m3U, and m5U by top-down mass spectrometry.

Authors:  Heidelinde Glasner; Christian Riml; Ronald Micura; Kathrin Breuker
Journal:  Nucleic Acids Res       Date:  2017-07-27       Impact factor: 16.971

Review 5.  Establishing Preferred Product Characterization for the Evaluation of RNA Vaccine Antigens.

Authors:  Cristina Poveda; Amadeo B Biter; Maria Elena Bottazzi; Ulrich Strych
Journal:  Vaccines (Basel)       Date:  2019-09-27

Review 6.  Stability Modelling of mRNA Vaccine Quality Based on Temperature Monitoring throughout the Distribution Chain.

Authors:  Zoltán Kis
Journal:  Pharmaceutics       Date:  2022-02-17       Impact factor: 6.321

7.  Quantifying the RNA cap epitranscriptome reveals novel caps in cellular and viral RNA.

Authors:  Jin Wang; Bing Liang Alvin Chew; Yong Lai; Hongping Dong; Luang Xu; Seetharamsingh Balamkundu; Weiling Maggie Cai; Liang Cui; Chuan Fa Liu; Xin-Yuan Fu; Zhenguo Lin; Pei-Yong Shi; Timothy K Lu; Dahai Luo; Samie R Jaffrey; Peter C Dedon
Journal:  Nucleic Acids Res       Date:  2019-11-18       Impact factor: 16.971

8.  High resolution biosensor to test the capping level and integrity of mRNAs.

Authors:  Ignacio Moya-Ramírez; Clement Bouton; Cleo Kontoravdi; Karen Polizzi
Journal:  Nucleic Acids Res       Date:  2020-12-16       Impact factor: 16.971

Review 9.  mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles.

Authors:  Andreas Ouranidis; Theofanis Vavilis; Evdokia Mandala; Christina Davidopoulou; Eleni Stamoula; Catherine K Markopoulou; Anna Karagianni; Kyriakos Kachrimanis
Journal:  Biomedicines       Date:  2021-12-27

Review 10.  Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials.

Authors:  Jill Whitley; Christopher Zwolinski; Christian Denis; Maureen Maughan; Leonie Hayles; David Clarke; Meghan Snare; Hong Liao; Sean Chiou; Tina Marmura; Holly Zoeller; Ben Hudson; John Peart; Monica Johnson; Amelia Karlsson; Yunfei Wang; Cynthia Nagle; Cherell Harris; Daniel Tonkin; Stephanie Fraser; Lieza Capiz; Christina L Zeno; Yvonne Meli; Diana Martik; Daniel A Ozaki; Amy Caparoni; Jason E Dickens; Drew Weissman; Kevin O Saunders; Barton F Haynes; Gregory D Sempowski; Thomas N Denny; Matthew R Johnson
Journal:  Transl Res       Date:  2021-12-04       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.